Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: July 1, 2021
A Multicenter, Prospective, Controlled, Longitudinal-Cohort Study Assessing the Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 50
  • Start Date: May 2021
Intestinal Microbiome Composition in Infants With Biliary Atresia
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Device
  • Participants: 50
  • Start Date: April 2021
Flexible Percutaneous Transhepatic Cholangiopancreatoscopy (PTCS) in Complex Pancreaticobiliary Disease
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 63
  • Start Date: March 19, 2021
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 200
  • Start Date: February 18, 2021
Clinical Validation of an Immunocytochemistry Method Using Antibody of Methionyl-tRNA Synthetase (MARS1) in the Bile Duct Cancer Cell; Multicenter Study
Clinical Trial
  • Status: Active, not recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 34
  • Start Date: February 14, 2021
Assessing the Feasibility and Acceptability of a 12-week Online Stress Reduction/Wellness Intervention for Primary Biliary Cholangitis: a Pre-post Single-arm Interventional Study
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 12
  • Start Date: February 2021
Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille Syndrome
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Device
  • Participants: 50
  • Start Date: January 18, 2021
Prospective Observational Cohort Study: To Assess the Performance of Single Use Duodenoscope
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 180
  • Start Date: January 11, 2021
RESPONSE: A Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of Seladelpar in Patients With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 290
  • Start Date: January 4, 2021
A Phase 2a/2b Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in Adult Women With Intrahepatic Cholestasis of Pregnancy and Elevated Serum Bile Acid Concentrations (OHANA).
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 30
  • Start Date: January 1, 2021
Jian-She Wang of Children's Hospital of Fudan University
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 200
  • Start Date: December 18, 2020
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
Showing 1-12 of 75